Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. [electronic resource]
Producer: 20060302Description: 2980-5 p. digitalISSN:- 1524-4539
- Adult
- Aged
- Blood Flow Velocity -- drug effects
- Connective Tissue Diseases -- complications
- Cross-Over Studies
- Double-Blind Method
- Drug Resistance
- Female
- Humans
- Male
- Middle Aged
- Patient Selection
- Piperazines -- adverse effects
- Purines
- Raynaud Disease -- drug therapy
- Scleroderma, Systemic -- complications
- Sildenafil Citrate
- Sulfones
- Treatment Outcome
- Vasodilation
- Vasodilator Agents -- adverse effects
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.